comparemela.com

Latest Breaking News On - Hims hers health stock performance - Page 1 : comparemela.com

Hims & Hers Health (NYSE:HIMS) Trading 5.7% Higher After Insider Buying Activity

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) rose 5.7% on Monday after an insider bought additional shares in the company. The stock traded as high as $22.10 and last traded at $21.97. Approximately 2,810,538 shares traded hands during mid-day trading, a decline of 59% from the average daily volume of 6,811,084 shares. […]

United-states
Switzerland
United-kingdom
Swiss
Oluyemi-okupe
Zurcher-kantonalbank-zurich-cantonalbank
Soleil-boughton
Piper-sandler
Hims-hers-health-stock-performance
Deutsche-bank-aktiengesellschaft
Securities-exchange-commission
Belpointe-asset-management

Insider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells $43,359.66 in Stock

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) insider Soleil Boughton sold 2,502 shares of the company’s stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $17.33, for a total transaction of $43,359.66. Following the transaction, the insider now directly owns 156,855 shares […]

United-states
Switzerland
United-kingdom
Swiss
Soleil-boughton
Leerink-partnrs
Hims-hers-health-stock-performance
Quarter-for-hims-hers-health
Forerunner-ventures-management
Hims-hers-health-inc
Securities-exchange-commission
Citigroup

Hims & Hers Health (NYSE:HIMS) Reaches New 52-Week High at $21.16

Hims & Hers Health (NYSE:HIMS) Reaches New 52-Week High at $21.16
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United-states
United-kingdom
Soleil-boughton
Piper-sandler
Andrew-dudum
News-ratings-for-hims-hers-health-daily
Canaccord-genuity-group
Hims-hers-health
Charles-schwab-investment-management-inc
Dimensional-fund-advisors
Farallon-capital-management
Forerunner-ventures-management

Citigroup Lowers Hims & Hers Health (NYSE:HIMS) to Neutral

Citigroup cut shares of Hims & Hers Health (NYSE:HIMS – Free Report) from a buy rating to a neutral rating in a research report sent to investors on Wednesday morning, Marketbeat reports. The firm currently has $20.00 target price on the stock, up from their prior target price of $16.00. A number of other research […]

United-states
United-kingdom
Leerink-partnrs
Irene-becklund
Soleil-boughton
Belpointe-asset-management
Securities-exchange-commission
Hims-hers-health-inc
Citigroup
Investment-advisers
Insider-transactions-at-hims-hers-health
Hims-hers-health

Hims & Hers Health (NYSE:HIMS) Shares Gap Down Following Insider Selling

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report)’s share price gapped down before the market opened on Wednesday following insider selling activity. The stock had previously closed at $17.56, but opened at $17.11. Hims & Hers Health shares last traded at $16.71, with a volume of 1,528,158 shares traded. Specifically, insider Soleil Boughton […]

Switzerland
United-kingdom
United-states
Swiss
Soleil-boughton
Patrick-harrison-carroll
Piper-sandler
York-mellon-corp
Canaccord-genuity-group
Securities-exchange-commission
Forerunner-ventures-management
Swiss-national-bank

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.